Your browser doesn't support javascript.
loading
Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia.
Chapman, Lloyd A C; Aubry, Maite; Maset, Noémie; Russell, Timothy W; Knock, Edward S; Lees, John A; Mallet, Henri-Pierre; Cao-Lormeau, Van-Mai; Kucharski, Adam J.
Afiliación
  • Chapman LAC; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK. l.chapman4@lancaster.ac.uk.
  • Aubry M; Department of Mathematics and Statistics, Lancaster University, Lancaster, UK. l.chapman4@lancaster.ac.uk.
  • Maset N; Laboratoire de recherche sur les infections virales émergentes, Institut Louis Malardé, Tahiti, French Polynesia.
  • Russell TW; Cellule Epi-surveillance Plateforme COVID-19, Tahiti, French Polynesia.
  • Knock ES; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Lees JA; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
  • Mallet HP; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
  • Cao-Lormeau VM; European Molecular Biology Laboratory, European Bioinformatics Institute EMBL-EBI, Cambridgeshire, UK.
  • Kucharski AJ; Cellule Epi-surveillance Plateforme COVID-19, Tahiti, French Polynesia.
Nat Commun ; 14(1): 7330, 2023 11 13.
Article en En | MEDLINE | ID: mdl-37957160
ABSTRACT
Estimating the impact of vaccination and non-pharmaceutical interventions on COVID-19 incidence is complicated by several factors, including successive emergence of SARS-CoV-2 variants of concern and changing population immunity from vaccination and infection. We develop an age-structured multi-strain COVID-19 transmission model and inference framework to estimate vaccination and non-pharmaceutical intervention impact accounting for these factors. We apply this framework to COVID-19 waves in French Polynesia and estimate that the vaccination programme averted 34.8% (95% credible interval 34.5-35.2%) of 223,000 symptomatic cases, 49.6% (48.7-50.5%) of 5830 hospitalisations and 64.2% (63.1-65.3%) of 1540 hospital deaths that would have occurred in a scenario without vaccination up to May 2022. We estimate the booster campaign contributed 4.5%, 1.9%, and 0.4% to overall reductions in cases, hospitalisations, and deaths. Our results suggest that removing lockdowns during the first two waves would have had non-linear effects on incidence by altering accumulation of population immunity. Our estimates of vaccination and booster impact differ from those for other countries due to differences in age structure, previous exposure levels and timing of variant introduction relative to vaccination, emphasising the importance of detailed analysis that accounts for these factors.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido